| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Caribou Biosciences, Inc. | Director | Option to purchase Common Stock | 39.5K | $106K | $2.69 | Feb 20, 2024 | Direct |
| Harpoon Therapeutics, Inc. | Chief Medical Officer | Employee Stock Option (right to buy) | 155K | Jan 28, 2022 | Direct | ||
| Zymeworks Inc. | Director | Stock Option (Right to Buy) | 25K | Dec 21, 2022 | Direct | ||
| Zymeworks Inc. | Director | Stock Option (Right to Buy) | 9K | May 6, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CRBU | Caribou Biosciences, Inc. | Feb 20, 2024 | 1 | $0 | 4 | Feb 22, 2024 | Director |
| CRBU | Caribou Biosciences, Inc. | Feb 21, 2023 | 1 | $0 | 4 | Feb 23, 2023 | Director |
| ZYME | Zymeworks Inc. | Dec 21, 2022 | 1 | $0 | 4 | Dec 23, 2022 | Director |
| HARP | Harpoon Therapeutics, Inc. | Jan 28, 2022 | 1 | $0 | 4 | Feb 1, 2022 | Chief Medical Officer |
| CRBU | Caribou Biosciences, Inc. | Dec 20, 2021 | 1 | $0 | 4 | Dec 21, 2021 | Director |
| HARP | Harpoon Therapeutics, Inc. | Nov 11, 2021 | 1 | $0 | 4 | Nov 15, 2021 | Chief Medical Officer |
| CRBU | Caribou Biosciences, Inc. | Jul 22, 2021 | 0 | $0 | 3 | Jul 22, 2021 | Director |
| ZYME | Zymeworks Inc. | May 6, 2021 | 1 | $0 | 4 | May 7, 2021 | Director |